Reports for PHARMASCIENCE INC
Formerly known as PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Shortage reports
Actual shortage:
53 (4%)
Anticipated shortage:
1 (0%)
Avoided shortage:
37 (3%)
Resolved:
1283 (93%)
1374
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
10 (18%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2025-04-01 | 2025-05-21 | 253879 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2025-02-05 | 2025-03-17 | 249585 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2025-06-09 | 2025-06-20 | 259962 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2018-01-26 | 2018-05-18 | 37334 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2019-07-31 | 2020-06-10 | 90485 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-09-19 | 2017-10-11 | 22808 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-09-08 | 2018-04-19 | 21718 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32139 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-12-24 | 2019-12-24 | 102061 |
| PMS-SERTRALINE | 50MG | CAPSULE | Avoided shortage | 2019-11-15 | 2019-11-18 | 98853 |
| PMS-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-11-15 | 2019-11-18 | 98856 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-06-26 | 2023-08-07 | 196459 |
| PMS-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32134 |
| PMS-SILDENAFIL R | 20MG | TABLET | Resolved | 2019-01-16 | 2019-02-26 | 72638 |
| PMS-SILDENAFIL R | 20MG | TABLET | Resolved | 2019-05-09 | 2019-09-19 | 83705 |
| PMS-SILDENAFIL R | 20MG | TABLET | Resolved | 2019-06-28 | 2019-09-18 | 87998 |
| PMS-SILDENAFIL R | 20MG | TABLET | Resolved | 2017-05-11 | 2017-05-18 | 10118 |
| PMS-SILDENAFIL R | 20MG | TABLET | Resolved | 2018-09-19 | 2018-11-29 | 61891 |
| PMS-SILDENAFIL R | 20MG | TABLET | Resolved | 2025-11-24 | 2025-12-01 | 272454 |
| PMS-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-06-17 | 2020-10-26 | 118180 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2018-01-26 | 2018-01-26 | 37263 |